Publikasi Scopus 926 artikel (Per 14 Maret 2022)

Rohsiswatmo R., Azharry M., Sari T.T., Bahasoan Y., Wulandari D.
55533574600;57263156500;36519483600;57263337000;57204024903;
TLR2 and TLR4 expressions in late-onset neonatal sepsis: Is it a potential novel biomarker?
2021
Journal of Neonatal-Perinatal Medicine
14
3
361
367
1
Department of Child Health, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Rohsiswatmo, R., Department of Child Health, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Azharry, M., Department of Child Health, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Sari, T.T., Department of Child Health, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Bahasoan, Y., Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Wulandari, D., Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
BACKGROUND: Late-onset neonatal sepsis (LONS) detection is problematic as no single examinations (blood culture, c-reactive protein (CRP), procalcitonin (PCT)) are reliable. Toll-like receptors (TLRs), which detect the presence of pathogen-associated molecular patterns is a promising novel biomarker, but less studied in LONS. This study aimed to determine neutrophils and monocytes TLR2 and TLR4 expression in LONS and their diagnostic value. METHODS: A cross-sectional study conducted in May and June 2017 involving 52 neonates with clinical late-onset (>72 hours of age) sepsis. We examine complete blood count, I/T ratio, CRP, PCT, as well as TLR2 and TLR4 expression to compared with blood culture as the gold standard. We classified cases into proven or unproven sepsis. RESULT: The incidence of LONS was 32.6% in the subjects. The expression of TLR2 was low in LONS, while TLR4 was high. TLR4 neutrophil expression has 88.2% sensitivity, 20% specificity, 34.9% positive predictive value (PPV), 77.8% negative predictive value (NPV), and an AUC of 0.541. TLR4 monocyte expression has 92.1% sensitivity, 11.4% specificity, 34% PPV, 80% NPV, and an AUC of 0.528. The AUC of CRP is increased from 0.608 to 0.843 after combination with TLR4, comparable with CRP + PCT (AUC 0.829). CONCLUSION: The increase in TLR4 expression has good sensitivity but low specificity. TLR4 expression, in combination with CRP, could become a reliable biomarker for the diagnosis of LONS. © 2021-IOS Press. All rights reserved.
biomarker; c-reactive protein; Late-onset neonatal sepsis; procalcitonin; TLR2; TLR4
biological marker; C reactive protein; procalcitonin; toll like receptor 2; toll like receptor 4; biological marker; C reactive protein; TLR2 protein, human; TLR4 protein, human; toll like receptor 2; toll like receptor 4; Acinetobacter baumannii; Article; blood cell count; blood culture; controlled study; cross-sectional study; diagnostic test accuracy study; diagnostic value; female; gold standard; human; Klebsiella pneumoniae; late onset disorder; low birth weight; major clinical study; male; monocyte count; neutrophil count; newborn; newborn sepsis; nonhuman; predictive value; protein expression; receiver operating characteristic; sensitivity and specificity; sepsis; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Humans; Infant, Newborn; Neonatal Sepsis; Sepsis; Toll-Like Rec
IOS Press BV
19345798
33164948
Article
Q2
444
11146